Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Zhejiang Multiple Myeloma Active Trials & Centers
As of 2026-10-21, there are 45 active clinical trials for multiple myeloma hosted across 16 tertiary medical centers in Zhejiang (including The First Affiliated Hospital, Zhejiang University School of Medicine, The First Affiliated Hospital of Wenzhou Medical University, The Second Affiliated Hospital, Zhejiang University School of Medicine, etc.).
Participating Medical Centers (16)
Active Studies in Zhejiang (45)
Population synthesized by CMDNShowing 0 published English records of 45 registry trials.
All 45 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.